Literature DB >> 21720016

α-Synuclein aggregation and transmission are enhanced by leucine-rich repeat kinase 2 in human neuroblastoma SH-SY5Y cells.

Kazunari Kondo1, Saemi Obitsu, Reiko Teshima.   

Abstract

Formation of α-synuclein aggregates is a key step in Parkinson's disease pathogenesis although the etiology remains elusive. α-Synuclein is accumulated in degenerating neurons, leading to the production of filamentous inclusions such as Lewy bodies. However, the in vitro overexpression of α-synuclein alone failed to induce inclusion bodies consisting of phosphorylated α-synuclein. The seeded aggregates-initiated polymerization of α-synuclein and tau has been reported elsewhere. What molecule is an initiator of filamentous inclusions remains to be defined. Here, we report that leucine-rich repeat kinase 2 (LRRK2)-cotransfection together with α-synuclein enhance the aggregate formation, phosphorylation, release to extracellular media of α-synuclein, and the cell-to-cell transmission into neighboring cells in human neuroblastoma SH-SY5Y cells. In cells transfected with α-synuclein alone, the proteins were distributed in the cytosol and did not form inclusions. On the other hand, the inclusions and phosphorylation of α-synuclein were formed in cells cotransfected with α-synuclein and LRRK2 G2019S mutant together. LRRK2 G2019S-cotransfected PC12 cells also induced the aggregates. Furthermore, the cell-to-cell transmission of α-synuclein and the cell toxicity were also enhanced by either LRRK2 wild type or G2019S mutant, whereas the cell viability was not decreased in cells transfected with α-synuclein alone. These results suggest that overexpression of LRRK2, especially G2019S mutant, whose functions remain unclear, initiate the aggregate formation, release and transmission of α-synuclein, resulting in the propagation of α-synuclein to neighboring cells and reduction of cell viability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720016     DOI: 10.1248/bpb.34.1078

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  24 in total

1.  The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway.

Authors:  José M Bravo-San Pedro; Mireia Niso-Santano; Rubén Gómez-Sánchez; Elisa Pizarro-Estrella; Ana Aiastui-Pujana; Ana Gorostidi; Vicente Climent; Rakel López de Maturana; Rosario Sanchez-Pernaute; Adolfo López de Munain; José M Fuentes; Rosa A González-Polo
Journal:  Cell Mol Life Sci       Date:  2012-07-08       Impact factor: 9.261

Review 2.  LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.

Authors:  A Raquel Esteves; Russell H Swerdlow; Sandra M Cardoso
Journal:  Exp Neurol       Date:  2014-06-04       Impact factor: 5.330

Review 3.  The unlikely partnership between LRRK2 and α-synuclein in Parkinson's disease.

Authors:  Noémie Cresto; Camille Gardier; Francesco Gubinelli; Marie-Claude Gaillard; Géraldine Liot; Andrew B West; Emmanuel Brouillet
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

4.  Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes.

Authors:  Saïda Abounit; Luc Bousset; Frida Loria; Seng Zhu; Fabrice de Chaumont; Laura Pieri; Jean-Christophe Olivo-Marin; Ronald Melki; Chiara Zurzolo
Journal:  EMBO J       Date:  2016-08-22       Impact factor: 11.598

5.  Trans-cellular propagation of Tau aggregation by fibrillar species.

Authors:  Najla Kfoury; Brandon B Holmes; Hong Jiang; David M Holtzman; Marc I Diamond
Journal:  J Biol Chem       Date:  2012-03-29       Impact factor: 5.157

6.  LRRK2 Promotes Tau Accumulation, Aggregation and Release.

Authors:  Patrícia Silva Guerreiro; Ellen Gerhardt; Tomás Lopes da Fonseca; Mathias Bähr; Tiago Fleming Outeiro; Katrin Eckermann
Journal:  Mol Neurobiol       Date:  2015-05-27       Impact factor: 5.590

Review 7.  Iron in neurodegenerative disorders of protein misfolding: a case of prion disorders and Parkinson's disease.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Matthew K McElwee; Katharine Horback; Amber Beserra
Journal:  Antioxid Redox Signal       Date:  2014-02-27       Impact factor: 8.401

8.  The potential of iPS cells in synucleinopathy research.

Authors:  Leonhard Linta; Marianne Stockmann; Tobias M Boeckers; Alexander Kleger; Stefan Liebau
Journal:  Stem Cells Int       Date:  2012-03-18       Impact factor: 5.443

Review 9.  The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease.

Authors:  Hardy J Rideout; Leonidas Stefanis
Journal:  Neurochem Res       Date:  2013-06-01       Impact factor: 3.996

Review 10.  Neuronal autophagy and mitophagy in Parkinson's disease.

Authors:  Britney N Lizama; Charleen T Chu
Journal:  Mol Aspects Med       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.